This inventor holds 39 USPTO granted patents, primarily in Pro-Drug Chemistry. Top assignees: American Cyanamid Company, Other. Active years: 1978-1993.
Location History:
- Pear River, NY (US) (1978)
- Pearl River, NY (US) (1978 - 1993)
Company Filing History:
38 out of 3,580Â 
1 out of 834,307Â Years Active: 1978-1993
Areas of Expertise:
Title: Innovations of Keith C Murdock: A Pioneer in Pro-drug Development
Introduction
Keith C Murdock, based in Pearl River, NY, is an accomplished inventor with a remarkable portfolio of 39 patents. His work primarily focuses on the development of innovative pro-drugs, enhancing drug solubility and reducing toxicity, thus opening new avenues in pharmaceutical science.
Latest Patents
Murdock's latest patents are significant contributions to the field of medicinal chemistry. One of his key inventions includes "Anthracycline derivatives as solubilized pro-drugs," which involves the N-phosphorylation of basic nitrogenous drug compounds. This groundbreaking approach produces pro-drugs characterized by enhanced water solubility or lipid solubility, and reduced toxicity. The designed pro-drugs contain various functional groups such as amine, amidine, guanidine, isourea, isothiourea, and biguanide functions. Importantly, these pro-drugs are hydrolyzed within the body, regenerating the original drugs and liberating a salt of phosphoric acid.
Another notable patent by Murdock is "Quinolinecarboxylic acid derivatives as solubilized pro-drugs," echoing the same innovative concept of N-phosphorylation to create pro-drugs that display enhanced solubility and lowered toxicity. These advancements underscore his commitment to improving therapeutic options available for patients.
Career Highlights
Throughout his career, Murdock has collaborated with prominent organizations in the pharmaceutical industry, notably American Cyanamid Company. His contributions to drug development and formulation have established him as a key figure in the field, particularly in advancing the efficiency of drug delivery systems.
Collaborations
Murdock has worked alongside several distinguished professionals, including Frederick E Durr and Ving J Lee. These collaborations have facilitated a cross-pollination of ideas that have advanced their respective research efforts.
Conclusion
Keith C Murdock's innovations and extensive patent portfolio significantly contribute to pharmaceutical advancements. His work in the development of pro-drugs, aimed at improving drug solubility and reducing toxicity, exemplifies the critical role inventors play in creating safer and more effective medical treatments. With a continued focus on improving drug delivery systems, Murdock remains a vital figure in the evolution of pharmaceutical sciences.